- Home
- BOX vs EWTX Comparison
BOX vs EWTX Comparison
Compare BOX & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | EWTX |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | N/A | 127 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BOX | EWTX |
|---|---|---|
| Price | $31.37 | $39.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $35.57 | ★ $39.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.2M |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $506,142,000.00 | N/A |
| Revenue This Year | $9.41 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $179.56 | ★ N/A |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $21.34 | $14.25 |
| 52 Week High | $36.34 | $48.51 |
Technical Indicators
Market Signals| Indicator | BOX | EWTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.00 | 37.04 |
| Support Level | $23.52 | $37.50 |
| Resistance Level | $31.83 | $41.04 |
| Average True Range (ATR) | 0.95 | 2.27 |
| MACD | -0.45 | -0.54 |
| Stochastic Oscillator | 1.56 | 8.80 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.